Ipca Laboratories Limited (NSE:IPCALAB)
1,477.10
-8.30 (-0.56%)
Feb 16, 2026, 11:49 AM IST
Ipca Laboratories Employees
Ipca Laboratories had 16,778 employees as of March 31, 2025. The number of employees decreased by 557 or -3.21% compared to the previous year.
Employees
16,778
Change (1Y)
-557
Growth (1Y)
-3.21%
Revenue / Employee
5.67M INR
Profits / Employee
542.30K INR
Market Cap
376.85B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 16,778 | -557 | -3.21% |
| Mar 31, 2024 | 17,335 | 1,168 | 7.22% |
| Mar 31, 2023 | 16,167 | 1,012 | 6.68% |
| Mar 31, 2022 | 15,155 | 581 | 3.99% |
| Mar 31, 2021 | 14,574 | 508 | 3.61% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Glenmark Pharmaceuticals | 15,800 |
| Ajanta Pharma | 9,628 |
| Emcure Pharmaceuticals | 6,731 |
| Laurus Labs | 6,167 |
| Piramal Pharma | 5,476 |
Ipca Laboratories News
- 2 days ago - Ipca Laboratories Q3 Results: Net profit jumps 31.5% YoY to Rs 326.27 crore, revenue up 6.55% - Business Upturn
- 9 days ago - Ipca Laboratories receives US FDA VAI status for Tarapur API facility - Business Upturn
- 2 months ago - This brokerage firm advises to Buy IPCA Labs shares and expects nearly 20% upside in stock price - Business Upturn
- 3 months ago - Ipca Laboratories Ltd (BOM:524494) Q2 2026 Earnings Call Highlights: Strong Domestic Growth ... - GuruFocus
- 3 months ago - Q2 2026 IPCA Laboratories Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Ipca Laboratories Q2 FY26 results: Revenue up 9% YoY to Rs 2,556.5 crore, Net profit rises 23% - Business Upturn
- 5 months ago - Ipca and BioSimilar Sciences sign Technology Transfer Agreement for next-gen cancer and anti-inflammatory biosimilar - Business Upturn
- 6 months ago - Ipca Laboratories Q1 results: Net profit surges 21% YoY to Rs 233.21 crore, revenue up 10.3% - Business Upturn